ALFA FinderBSE filing, NSE: PGHL. Summary written from the filing by ALFA Finder's alert engine.
Procter & Gamble Health Ltd: key numbers
- Share price
- ₹5,722.00
- Market cap
- ₹9,498 Cr
- Revenue (annual)
- ₹1,408 Cr
- Net profit (annual)
- ₹326.9 Cr
- P/E (TTM)
- 25.0×Sector 43.8×
- Promoter holding
- 51.82%+0.00% QoQ
- FII holding
- 6.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Health Ltd
All →Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
Procter & Gamble Health Q2 FY27 Results: Net Profit ₹111.5 Cr, Up 26.0% YoY
Procter & Gamble Health Ltd reported revenue from operations of ₹382.5 Cr (+17.7% YoY) and net profit of ₹111.5 Cr (+26.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹111.5 Cr · +26.0% YoY
Procter & Gamble Health Board Meeting Date
Procter & Gamble Health Limited will hold a board meeting on November 2, 2026, to consider and approve the unaudited financial results for the quarter ending September 30, 2026.
Procter & Gamble Health Other Announcement
Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.
Procter & Gamble Health Management Change
Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.
- Execution
- 5 years
Procter & Gamble Health Annual General Meeting
Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.
Other other announcement announcements
All →Switching Technologies Gunther Other Announcement
Switching Technologies Gunther disclosed half-year related party transactions to September 2026 under Reg 23(9). It is routine periodic disclosure, not a single new deal.
Sai Silks (Kalamandir) Other Announcement
CARE Ratings' monitoring report on Sai Silks' Rs.600 crore IPO proceeds shows no deviation from objects. It notes delays in warehouse spending, with Rs.20.27 crore unutilised.
Thermax Other Announcement
Thermax Ltd informed exchanges that its RTA, KFin Technologies, will shift its Corporate Office to a new Hyderabad address from December 1, 2026. The Registered Office is unchanged, and this is an administrative update.
Indostar Capital Finance Other Announcement
Director Hemant Kaul bought 5,001 Indostar Capital shares via market purchases from 11 to 13 November 2026. The trades total about Rs 0.10 Crore.
- Value
- ₹0.10 Cr
SMS Pharmaceuticals Other Announcement
SMS Pharmaceuticals' employee immediate relative sold 2,000 shares worth Rs.0.11 Crore on NSE on 11 November 2026. The holding fell to 18,905 shares, still 0.02%.
- Value
- ₹0.11 Cr
Sheel Biotech Other Announcement
Sheel Biotech filed its CARE-issued monitoring agency report for the half year ended September 30, 2026. The report confirms IPO proceeds were fully utilised with no deviation.